iShares 5-10 Year Invmt Grd Corp Bd ETF
Why NightStar Therapeutics Is Soaring Today
Today, Nightstar Therapeutics (NITE) is trading close to $25.17, which is about 66% higher than its previous closing price.
Analysts Remain Bullish on BioMarin Pharmaceutical
Of the 23 analysts covering BioMarin Pharmaceutical (BMRN) in September, 19 of them have given the stock a “buy” or higher rating.
Analyzing Audentes Therapeutics’ Valuation Metrics
Audentes Therapeutics (BOLD) incurred a net loss of $31.37 million in the second quarter compared with $22.74 million in Q2 2017.